PRA worked with an emerging biotech firm to implement a first-in-human clinical trial using a live biotherapeutic product for a rare disease indication.
Explore related content and topics
Blog
Tips for Managing Stress During COVID-19
With so much uncertainty about the future of our health, economy, and the state of the world, our mental health is put at risk. According to the…
Read Story
Poster
Pharmacokinetic Charcateristic of Oral_Intranasal Morphine ARER
Extended-release (ER) opioid formulations are often targeted for misuse and abuse because they contain high amounts of opioid. An oral…
View Resource
Poster
Real-World Misuse Abuse and Dependence of Abuse Deterrent
Abuse deterrent formulations of opioid medications (ADOs) may help curtail the widespread abuse, misuse, and diversion of these products.With the…
View Resource
View all related content and resources for Scientific Affairs
Explore Insights